Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1989 Sep;65(767):622–627. doi: 10.1136/pgmj.65.767.622

The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus.

J G Hanly 1, S Behmann 1, S D Denburg 1, R M Carbotte 1, J A Denburg 1
PMCID: PMC2429197  PMID: 2608589

Abstract

To determine the significance of changes in serum antineuronal antibody levels in systemic lupus erythematosus, 9 patients who had a rise and 11 patients who had a fall in neuronal antibody titre over a mean duration of 2.1 years (range 0.25-5.2) were identified. These changes were examined in the light of concurrent changes in other serological variables, overall disease activity, neuropsychiatric disease and neuropsychological tests. Changes in antineuronal antibodies were frequently associated with concurrent changes in anti-DNA antibodies and overall disease activity. When neuropsychiatric disease or cognitive dysfunction were present, their course showed a close correlation with changes in antineuronal antibody levels. The results support the association between antineuronal antibodies and neuropsychiatric-systemic lupus erythematosus, but suggest that their measurement will provide useful information of disease status in only a subpopulation of patients.

Full text

PDF
622

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bluestein H. G. Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3965–3969. doi: 10.1073/pnas.75.8.3965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bluestein H. G., Williams G. W., Steinberg A. D. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med. 1981 Feb;70(2):240–246. doi: 10.1016/0002-9343(81)90756-7. [DOI] [PubMed] [Google Scholar]
  3. Bonfa E., Golombek S. J., Kaufman L. D., Skelly S., Weissbach H., Brot N., Elkon K. B. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med. 1987 Jul 30;317(5):265–271. doi: 10.1056/NEJM198707303170503. [DOI] [PubMed] [Google Scholar]
  4. Bresnihan B. CNS lupus. Clin Rheum Dis. 1982 Apr;8(1):183–195. [PubMed] [Google Scholar]
  5. Bresnihan B., Oliver M., Williams B., Hughes G. R. An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum. 1979 Apr;22(4):313–320. doi: 10.1002/art.1780220401. [DOI] [PubMed] [Google Scholar]
  6. Carbotte R. M., Denburg S. D., Denburg J. A. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis. 1986 Jun;174(6):357–364. doi: 10.1097/00005053-198606000-00008. [DOI] [PubMed] [Google Scholar]
  7. Denburg S. D., Carbotte R. M., Denburg J. A. Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol. 1987 Aug;9(4):323–339. doi: 10.1080/01688638708405054. [DOI] [PubMed] [Google Scholar]
  8. Estes D., Christian C. L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971 Mar;50(2):85–95. doi: 10.1097/00005792-197103000-00001. [DOI] [PubMed] [Google Scholar]
  9. Golombek S. J., Graus F., Elkon K. B. Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Rheum. 1986 Sep;29(9):1090–1097. doi: 10.1002/art.1780290906. [DOI] [PubMed] [Google Scholar]
  10. Hanly J. G., Rajaraman S., Behmann S., Denburg J. A. A novel neuronal antigen identified by sera from patients with systemic lupus erythematosus. Arthritis Rheum. 1988 Dec;31(12):1492–1499. doi: 10.1002/art.1780311205. [DOI] [PubMed] [Google Scholar]
  11. How A., Dent P. B., Liao S. K., Denburg J. A. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1985 Jul;28(7):789–795. doi: 10.1002/art.1780280710. [DOI] [PubMed] [Google Scholar]
  12. Hughes G. R. Central nervous system lupus--diagnosis and treatment. J Rheumatol. 1980 May-Jun;7(3):405–411. [PubMed] [Google Scholar]
  13. Inoue T., Okamura M., Amatsu K., Ohe A., Kato N., Kanayama Y. Antineuronal antibodies in brain tissue of patient with systemic lupus erythematosus. Lancet. 1982 Apr 10;1(8276):852–852. doi: 10.1016/s0140-6736(82)91897-9. [DOI] [PubMed] [Google Scholar]
  14. Kelly M. C., Denburg J. A. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions. J Rheumatol. 1987 Aug;14(4):740–744. [PubMed] [Google Scholar]
  15. Lee P., Urowitz M. B., Bookman A. A., Koehler B. E., Smythe H. A., Gordon D. A., Ogryzlo M. A. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med. 1977 Jan;46(181):1–32. [PubMed] [Google Scholar]
  16. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  17. Pischel K. D., Bluestein H. G., Woods V. L., Jr Very late activation antigens (VLA) are human leukocyte-neuronal crossreactive cell surface antigens. J Exp Med. 1986 Aug 1;164(2):393–406. doi: 10.1084/jem.164.2.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rubin L. A., Urowitz M. B., Gladman D. D. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med. 1985 Apr;55(216):87–98. [PubMed] [Google Scholar]
  19. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  20. Urowitz M. B., Gladman D. D., Tozman E. C., Goldsmith C. H. The lupus activity criteria count (LACC). J Rheumatol. 1984 Dec;11(6):783–787. [PubMed] [Google Scholar]
  21. Wilson H. A., Winfield J. B., Lahita R. G., Koffler D. Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus. Arthritis Rheum. 1979 May;22(5):458–462. doi: 10.1002/art.1780220504. [DOI] [PubMed] [Google Scholar]
  22. Zvaifler N. J., Bluestein H. G. The pathogenesis of central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum. 1982 Jul;25(7):862–866. doi: 10.1002/art.1780250730. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES